Eculizumab treatment for rescue of renal function in IgA nephropathy |
| |
Authors: | Therese Rosenblad Johan Rebetz Martin Johansson Zivile Békássy Lisa Sartz Diana Karpman |
| |
Institution: | 1. Section of Pediatric Nephrology, Department of Pediatric and Adolescent Medicine, Sk?ne University Hospital, Lund, Sweden 2. Department of Pediatrics, Clinical Sciences Lund, Lund University, Lund, 22185, Sweden 3. Department of Pathology, Sk?ne University Hospital, Malm?, Sweden 4. Department of Laboratory Medicine Malm?, Center for Molecular Pathology, Lund University, Malm?, Sweden
|
| |
Abstract: | Background Immunoglobulin A (IgA) nephropathy is a chronic glomerulonephritis with excessive glomerular deposition of IgA1, C3 and C5b-9, which may lead to renal failure. Case Diagnosis/Treatment We describe the clinical course of an adolescent with rapidly progressive disease leading to renal failure in spite of immunosuppressive treatment. Due to refractory disease the patient was treated with eculizumab (anti-C5) for 3 months in an attempt to rescue renal function. Treatment led to clinical improvement with stabilization of the glomerular filtration rate and reduced proteinuria. Discontinuation of treatment led to a rapid deterioration of renal function. This was followed by a single dose of eculizumab, which again reduced creatinine levels temporarily. Conclusions Early initiation of eculizumab therapy in patients with progressive IgA nephropathy may have a beneficial effect by blocking complement-mediated renal inflammation. |
| |
Keywords: | |
本文献已被 SpringerLink 等数据库收录! |
|